{{Rsnum
|rsid=2134688
|Gene=ARNT
|Chromosome=1
|position=150844410
|Orientation=plus
|GMAF=0.1713
|Gene_s=ARNT
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 84.1 | 15.9 | 0.0
| HCB | 59.9 | 32.1 | 8.0
| JPT | 74.3 | 24.8 | 0.9
| YRI | 42.9 | 45.6 | 11.6
| ASW | 45.6 | 33.3 | 21.1
| CHB | 59.9 | 32.1 | 8.0
| CHD | 57.8 | 37.6 | 4.6
| GIH | 81.2 | 16.8 | 2.0
| LWK | 40.0 | 47.3 | 12.7
| MEX | 84.5 | 15.5 | 0.0
| MKK | 51.9 | 41.0 | 7.1
| TSI | 83.3 | 16.7 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=24353446
|Title=Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel response
|OA=1
}}

{{PMID Auto
|PMID=18366646
|Title=Aryl hydrocarbon receptor nuclear translocator (ARNT) gene as a positional and functional candidate for type 2 diabetes and prediabetic intermediate traits: Mutation detection, case-control studies, and gene expression analysis.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}